These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31390012)

  • 1. Plasma Metabolomics to Identify and Stratify Patients With Impaired Glucose Tolerance.
    Wildberg C; Masuch A; Budde K; Kastenmüller G; Artati A; Rathmann W; Adamski J; Kocher T; Völzke H; Nauck M; Friedrich N; Pietzner M
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6357-6370. PubMed ID: 31390012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel test for IGT utilizing metabolite markers of glucose tolerance.
    Cobb J; Eckhart A; Perichon R; Wulff J; Mitchell M; Adam KP; Wolfert R; Button E; Lawton K; Elverson R; Carr B; Sinnott M; Ferrannini E
    J Diabetes Sci Technol; 2015 Jan; 9(1):69-76. PubMed ID: 25261439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Serum PCSK9 Levels in Subjects with Normoglycemia, Impaired Fasting Glucose, and Impaired Glucose Tolerance.
    Han E; Cho NH; Moon SS; Cho H
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):480-483. PubMed ID: 32615732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
    Xiao J; Tian H; Li CL; Zhong WW; Sun BR; Li YP; Fang FS; Han XF; Liu YQ; Cheng XL
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):299-303. PubMed ID: 22781951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin, soluble transferrin receptor and IL-6 levels in obese children and adolescents with and without type 2 diabetes mellitus/impaired glucose tolerance and their association with obstructive sleep apnea.
    Shalitin S; Deutsch V; Tauman R
    J Endocrinol Invest; 2018 Aug; 41(8):969-975. PubMed ID: 29305826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk.
    Defronzo RA; Tripathy D; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Clement SC; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD; Gastaldelli A;
    Diabetes Care; 2013 Nov; 36(11):3607-12. PubMed ID: 24062330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myonectin Predicts the Development of Type 2 Diabetes.
    Li K; Liao X; Wang K; Mi Q; Zhang T; Jia Y; Xu X; Luo X; Zhang C; Liu H; Zhen H; Li L; Yang G
    J Clin Endocrinol Metab; 2018 Jan; 103(1):139-147. PubMed ID: 29161407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
    Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Isoleucine, Sarcosine, and Dimethylglycine During OGTT as Risk Factors for Diabetes.
    Liu Y; Liu X; He Q; Huang X; Ren Y; Dong Z
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1793-1802. PubMed ID: 38214112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test.
    Retnakaran R; Zinman B; Connelly PW; Sermer M; Hanley AJ
    Diabetes Care; 2006 Jan; 29(1):57-62. PubMed ID: 16373896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.